Square Pharmaceuticals PLC · DSEBD:SQURPHARMA

Square Pharmaceuticals PLC shareholders

Square Pharmaceuticals PLC on 6ix: holders from US fund reports. Largest: Siit Emerging Markets Equity Fund, Harding Loevner International Small Companies Portfolio and Parametric Tax-Managed Emerging Markets Fund. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
Siit Emerging Markets Equity Fund1.01MUS$1.73MNo changeMay 31, 2026
Harding Loevner International Small Companies Portfolio682KUS$1.22M−72,091Jul 31, 2026
Parametric Tax-Managed Emerging Markets Fund534KUS$971KNo changeJun 30, 2026
Harding Loevner Frontier Emerging Markets Portfolio447KUS$799KNo changeJul 31, 2026
Parametric Emerging Markets Fund196KUS$348K−61,346Jul 31, 2026
T. Rowe Price Global Allocation Fund20,079US$35,681−1,987Jul 31, 2026

Square Pharmaceuticals PLC insider trades